Those novel findings obtained by a series of CGH studies in addition to mutation analyses including the BRAF gene enabled progress in the research fields of molecular pathogenesis of melanomas in contrast to the previous concept, which was speculated from clinical and histopathological observations, that melanomas do not have enough evidence to subcategorize them into different subsets [55]. This evidence concerns the gene BRAF and melanoma.